Showing results (501-510 of 1,769) with videos related to

Sort By:
Pageof 177
Gynecologic Oncology Reports|March 4, 2022
Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER studyDaniel H Saris, Anna Jo Bodurtha Smith, Colleen Brensinger, et al.
Gynecologic Oncology Reports|March 28, 2022
Perivascular epithelioid cell tumor (PEComa) of the uterus: Challenges of pregnancy in determining prognosis and optimal treatmentAnnelise M Wilhite, Valeria Dal Zotto, Paige Pettus, et al.
Gynecologic Oncology Reports|December 13, 2023
Malignant neoplasms of the vagina: A 30-year review from the Republic of BelarusOlga P Matylevich, Maksim S Isachanka, Olga I Zubets, et al.
Gynecologic Oncology Reports|November 30, 2023
Efficacy of cyclin-dependent kinase 4/6 inhibitors in combination with hormonal therapy in patients with recurrent granulosa cell tumor of the ovary: A case seriesBenjamin B Albright, Stephanie Shuey, Angeles Alvarez Secord, et al.
Gynecologic Oncology Reports|November 29, 2023
Low grade endometrial stromal sarcoma in pregnancy: A case in support of safe abortion accessRachel L Furuya, David L Eisenberg, Diana L Gray, et al.
Gynecologic Oncology Reports|November 15, 2023
HPV-associated vulvar carcinoma with sebaceous differentiationIrena Kuan, Katherine Tian, Shannon Grabosch, et al.
Gynecologic Oncology Reports|September 18, 2023
Identifying barriers individuals face in accessing fertility care after a gynecologic cancer diagnosisJulia Schlossman, Michelle Vu, Alexandra Samborski, et al.
Gynecologic Oncology Reports|August 28, 2023
A complete durable response of vaginal clear cell carcinoma with pembrolizumab: A case reportHector S Porragas-Paseiro, Saketh Guntupalli, Jessie Xiong, et al.
Gynecologic Oncology Reports|August 28, 2023
Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case reportM Lehmann, H Hosa, T Bartl, et al.
Gynecologic Oncology Reports|August 28, 2023
Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbiditiesAbdelrahman AlAshqar, Maddie Ghazarian, Emily M Webster, et al.
Pageof 177